Ortho Diagnostic Systems Inc is categorized under Blood Derivative Diagnostic Agents in Raritan, NJ and active since 1974.
Ortho Diagnostic Systems Inc was established in 1974, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a Blood Derivative Diagnostic Agents business, which does work in the B2B market, and is classified as a Blood Derivative Diagnostic Agents, under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Catherine Burzik at the company’s headquarters by writing to 1001 Us Highway 202, Raritan, New Jersey NJ 08869 or by phoning (908) 218-8000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ortho Diagnostic Systems Inc |
| Contact Person: | Catherine Burzik |
| Address: | 1001 Us Highway 202, Raritan, New Jersey 08869 |
| Phone Number: | (908) 218-8000 |
| Annual Revenue (USD): | $100.000.000 to $499.999.999 |
| Founded: | 1974 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Blood Derivative Diagnostic Agents |
| SIC Code: | 2835 |
| NAICS Code: | 325412 |
| Share This Business: |
Ortho Diagnostic Systems Inc was started in 1974 to provide professional Blood Derivative Diagnostic Agents under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.
Feel free to contact Catherine Burzik for inquiries that concern Ortho Diagnostic Systems Inc by calling the company number (908) 218-8000, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Ortho Diagnostic Systems Inc can be found at the coordinates 40.574193,-74.648594 as well as the street address 1001 Us Highway 202 in Raritan, New Jersey 08869.
For its online presence, you may visit Ortho Diagnostic Systems Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.